期刊文献+
共找到12篇文章
< 1 >
每页显示 20 50 100
重症急性胰腺炎的治疗 被引量:2
1
作者 温济民 《黑龙江医学》 2004年第3期171-172,共2页
重症急性胰腺炎是临床危重症之一。既往均采用急诊手术治疗 ,但死亡率很高。近年在大量应用胰酶抑制剂的前提下 ,可选择相关适应证进行保守疗法。本文就重症急性胰腺炎的治疗归类、手术治疗适应证、术式选择及保守治疗适应证和措施 。
关键词 内科学:重症:急性胰腺炎:治疗
下载PDF
自拟清胰汤治疗重症急性胰腺炎31例 被引量:6
2
作者 王洋 张莉 张瑞林 《世界中医药》 CAS 2011年第4期300-300,共1页
重症急性胰腺炎(SAP)又称急性出血坏死性胰腺炎,其起病急、进展快,并发症多,病情复杂且凶险,病死率高。我们在常规治疗的基础上加用自拟清胰汤治疗31例,疗效较好,现报道如下。
关键词 重症急性胰腺炎/内科综合治疗 @自拟清胰汤
下载PDF
连续性肾脏替代治疗重症急性胰腺炎及护理干预 被引量:1
3
作者 肖晓萍 《当代护士(中旬刊)》 2014年第8期67-68,共2页
目的观察连续性肾脏替代治疗及护理干预提高重症急性胰腺炎患者并发全身炎症反应综合症的抢救成功率。方法30例SAP患者全部并发全身炎症反应综合症,A组13例,B组17例。2组均常规行内科治疗及护理,此外B组早期(1~3d)采用连续性肾脏... 目的观察连续性肾脏替代治疗及护理干预提高重症急性胰腺炎患者并发全身炎症反应综合症的抢救成功率。方法30例SAP患者全部并发全身炎症反应综合症,A组13例,B组17例。2组均常规行内科治疗及护理,此外B组早期(1~3d)采用连续性肾脏替代疗法,连续性静一静脉血液滤过治疗及全面护理。观察2组愈后及监测血炎症因子指标。结果B组死亡率低于A组,治疗后各时期炎症因子浓度低于A组(P〈0.05)。结论连续性肾脏替代治疗在重症急性胰腺炎的治疗中有效正确的护理对患者的康复具有重要意义。 展开更多
关键词 连续性肾脏替代治疗{重症急性胰腺炎 全身炎症反应综合症 护理
下载PDF
中西医结合治疗重症急性胰腺炎疗效及安全性评价 被引量:5
4
作者 苑超 《临床研究》 2016年第11期183-184,共2页
目的 探究中西医结合治疗重症急性胰腺炎疗效及安全性.方法 选取2013年1月至2015年12月在我院进行SAP治疗的68例患者,将其分为A、B两组,A组进行常规治疗,B组进行中西药结合治疗,比较其治疗效果及安全性.结果 B组患者症状改善比例为79.41... 目的 探究中西医结合治疗重症急性胰腺炎疗效及安全性.方法 选取2013年1月至2015年12月在我院进行SAP治疗的68例患者,将其分为A、B两组,A组进行常规治疗,B组进行中西药结合治疗,比较其治疗效果及安全性.结果 B组患者症状改善比例为79.41%,A组为67.64%,,且B组患者疗效为痊愈及显效例数明显高于A组(P<0.05).A、B两组不良反应几率为11.76%及5.88%,差异显著(P<0.05),在治疗过程中发生严重脏器衰竭并导致死亡例数分别为3例及1例.结论 对SAP患者采用中西医结合治疗,可明显改善患者临床症状,且患者在治疗过程中出现的不良反应及死亡情况较低,对改善患者生活质量及健康水平均有明显优势. 展开更多
关键词 中西医结合重症急性胰腺炎治疗效果
下载PDF
妊娠晚期伴发急性重症胰腺炎手术治疗9例 被引量:1
5
作者 王斌 董文亮 +3 位作者 侯铁伟 初侃 王福荣 蔡相军 《沈阳部队医药》 2011年第2期123-124,共2页
妊娠晚期伴发急性重症胰腺炎(SAP)发病急,进展快,临床过程凶险,对母婴危害大。2005年1月~2010年1月期间。9例SAP患者经过积极的保守治疗无效,行手术治疗,治疗效果满意,现报告如下。
关键词 重症胰腺炎/手术治疗 妊娠并发症 妊娠晚期
下载PDF
复方丹参、低分子右旋糖酐佐治重症胰腺炎疗效观察 被引量:1
6
作者 孙翼 黄斌 +2 位作者 李腾海 黄锦秀 金红 《中国新医药》 2003年第6期66-67,共2页
目的 探讨丹参、低分子右旋糖酐在重症胰腺炎治疗中的作用。方法 采用ELISA法和单克隆酶联免疫吸附法检测72例重症胰腺炎患者和49例健康体检者的血浆内血小板a颗粒膜蛋白(GMP-140)、血栓烷B2(TxB2)、6-酮-前列腺素F1a(6-Keto-PGF)和... 目的 探讨丹参、低分子右旋糖酐在重症胰腺炎治疗中的作用。方法 采用ELISA法和单克隆酶联免疫吸附法检测72例重症胰腺炎患者和49例健康体检者的血浆内血小板a颗粒膜蛋白(GMP-140)、血栓烷B2(TxB2)、6-酮-前列腺素F1a(6-Keto-PGF)和血管性假血友病因子相关抗原(VWFAG)含量。用此法测定了凝血酶原时间(PT)。72例重症胰腺炎患者随机分为两组:一般治疗组和改善微循环组,疗程2周。结果 重症胰腺炎患者血浆GMP-140、TxB2和VWP.Ag含量明显高于对照组(P<0.01),6-Keto-PG甩和PT明显低于对照组(P<0,05)。丹参和低分子右旋糖酐治疗2周后血GMP一140、TXB2和VWF:Ag水平与治疗前相比明显下降,PT恢复正常。结论 重症胰睬炎患者存在高凝状态,丹参和低分子右旋糖酐能明显纠正重症胰腺炎患者的高凝状态,提高临床治愈率。 展开更多
关键词 重症胰腺炎治疗 疗效 低分子右旋糖酐 丹参 给药方法 测定方法
下载PDF
急性重症胰腺炎11例诊治体会 被引量:3
7
作者 颜兆寰 张彤 +1 位作者 黄荣根 邹海洪 《内科》 2015年第1期85-86,共2页
目的探讨急性重症胰腺炎的诊断和治疗方法。方法回顾性分析11例确诊的急性重症胰腺炎诊断和治疗经过。结果治愈9例,其中非手术治疗4例,合并胆石症转手术治疗5例,好转1例(转为慢性胰腺炎),死亡1例,死亡原因是多器官功能衰竭。结论急性重... 目的探讨急性重症胰腺炎的诊断和治疗方法。方法回顾性分析11例确诊的急性重症胰腺炎诊断和治疗经过。结果治愈9例,其中非手术治疗4例,合并胆石症转手术治疗5例,好转1例(转为慢性胰腺炎),死亡1例,死亡原因是多器官功能衰竭。结论急性重症胰腺炎的治疗以内科综合治疗为主,结合中医和手术治疗,早期诊断,早期治疗,临床上可以取得较满意的疗效。 展开更多
关键词 急性重症胰腺炎综合治疗 中医中药
下载PDF
重症急性胰腺炎172例诊治体会 被引量:3
8
作者 席鹏武 王成虎 +1 位作者 陈君 王华 《中国现代普通外科进展》 CAS 2009年第12期1094-1095,共2页
重症急性胰腺炎(severeacutepancreatitis.SAP)的病死率高达30%,发病急,临床表现复杂,病程进展迅速,极易引起多脏器功能损害,同时给患者精神和经济上带来严重负担。我院2000年1月-2008年12月共收治172例SAP,采用中西结合“个... 重症急性胰腺炎(severeacutepancreatitis.SAP)的病死率高达30%,发病急,临床表现复杂,病程进展迅速,极易引起多脏器功能损害,同时给患者精神和经济上带来严重负担。我院2000年1月-2008年12月共收治172例SAP,采用中西结合“个体化综合治疗”,总结报道如下。 展开更多
关键词 重症急性胰腺炎·诊断·治疗
下载PDF
早期肠内营养(<72h)与全肠外营养在SAP治疗中的价值评估:荟萃分析 被引量:7
9
作者 周鹏 耿小平 +5 位作者 赵红川 赵义军 王国斌 张志功 谢坤 周大臣 《肝胆外科杂志》 2013年第1期34-39,共6页
目的系统评价早期肠内营养(EEN)和全肠外营养(TPN)对重症急性胰腺炎(SAP)患者预后的影响。方法检索Pubmed(1997~2012.1)、EMbase(1984~2012.1)、Cochrane Central Register of Controlled Trials(Cochrane Library,2012.1)、CBM(1975... 目的系统评价早期肠内营养(EEN)和全肠外营养(TPN)对重症急性胰腺炎(SAP)患者预后的影响。方法检索Pubmed(1997~2012.1)、EMbase(1984~2012.1)、Cochrane Central Register of Controlled Trials(Cochrane Library,2012.1)、CBM(1975~2012.1),补充检索纳入研究的参考文献;对符合条件的文献进行资料提取及质量评估后,采用RevMan5.1软件进行分析。结果检索文献385篇,严格按照纳入标准并经过文献质量评估,共纳入14个RCT,合计701例患者(338例接受EEN治疗,363例接受TPN治疗),Meta分析结果显示:与TPN相比,EEN既能降低人工营养相关并发症的发生率,又可降低SAP患者的病死率;同时胰腺相关并发症、多器官功能衰竭及需要手术干预的几率均明显下降,但对于非胰腺相关并发症,两组营养支持的作用无显著性差异[OR=0.52,95%CI(0.26,1.04),P=0.06]。结论在SAP治疗过程中,EEN总体效果优于TPN,在无明显禁忌的情况下首先推荐使用EEN。 展开更多
关键词 重症胰腺炎治疗 早期肠内营养 全肠外营养 Mata分析
下载PDF
Experimental study of therapeutic efficacy of Baicalin in rats with severe acute pancreatitis 被引量:23
10
作者 Xi-Ping Zhang Ling Zhang +4 位作者 Jin-Xian He Rui-Ping Zhang Qi-Hui Cheng Yi-Feng Zhou Bei Lu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第5期717-724,共8页
AIM: To observe the therapeutic efficacy of Baicalin in rats with severe acute pancreatitis (SAP) and explore its therapeutic mechanisms. METHODS: The SAP rat models were randomly divided into the model control gr... AIM: To observe the therapeutic efficacy of Baicalin in rats with severe acute pancreatitis (SAP) and explore its therapeutic mechanisms. METHODS: The SAP rat models were randomly divided into the model control group, Baicalin treatment group, octreotide treatment group and sham operation group. All groups were randomly subdivided into 3 h, 6 h and 12 h groups with 15 rats in each group. The survival, ascites volume and pathological changes of pancreas in all rats were observed at different time points after operation. The plasma amylase content and serum TNF-α, IL-6, malonaldehyde (MDA) and PLA2 contents were also determined. RESULTS: The survival was not obviously different between the treated groups, and was significantly higher in treated groups at 12 h compared to the model control group (P 〈 0.05, 15 vs 10). The ascites/body weight ratio at 3 h and 6 h was significantly lower in Baicalin treatment group compared to the model control group and octreotide treatment group (P 〈 0.05, 1.00 vs 2.02 and 1.43 and P 〈 0.001, 2.29 (1.21) vs 2.70 (0.80) and 2.08 (2.21), respectively). The contents of amylase, TNF-α, IL-6, MDA and PLA2 were significantly lower in the treated groups than in the model control group (P 〈 0.05, 4342 vs 5303, 5058 vs 6272 in amylase, P 〈 0.01, 21.90 vs 36.30, 23.80 vs 39.70, 36 vs 54.35 in MDA and 56.25 vs 76.10 in PIA2, or P 〈 0.001, 65.10 and 47.60 vs 92.15 in TNF-α, 3.03 vs 5.44, 2.88 vs 6.82, 2.83 vs 5.36 in IL-6, respectively). The pathological scores of pancreas in the treated groups were significantly lower than that in the model control group (P 〈 0.05, 9.00 vs 10.05, 6.00 vs 9.00, 8.00 vs 10.05), but no marked difference was found between the treated groups. CONCLUSION: The Baicalin injection has significant therapeutic effects on SAP rats, its effects are similar to those of octreotide. The Baicalin injection is also cheap and has a big application range, quite hopefully to be used in clinical treatment of SAP. 展开更多
关键词 Severe acute pancreatitis BAICALIN Octreotide Rats Serum amylase TNF-α IL-6 MALONALDEHYDE PLA2
下载PDF
Review:Advances in researches on the immune dysregulation and therapy of severe acute pancreatitis 被引量:16
11
作者 Xi-ping ZHANG Han-qing CHEN +1 位作者 Fang LIU Jie ZHANG 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2009年第7期493-498,共6页
During the development and progression of severe acute pancreatitis(SAP) ,conspicuous immune dysregulation develops,which is mainly manifested as excessive immune response in the early stage and immunosuppression in t... During the development and progression of severe acute pancreatitis(SAP) ,conspicuous immune dysregulation develops,which is mainly manifested as excessive immune response in the early stage and immunosuppression in the late stage. This process involves complex changes in a variety of immune molecules and cells,such as cytokines,complements,lymphocytes,and leukocytes. With the gradual deepening of studies on the development and progression of SAP,the role of immune dysregulation in the pathogenesis of SAP has attracted more and more attention. In this article,we review the advances in research on the immune dysregulation in SAP and the immunotherapy of this disease through exploring the formation of excessive immune response and immune suppression as well as their mutual transformation. 展开更多
关键词 Severe acute pancreatitis (SAP) IMMUNE DYSREGULATION Treatment
原文传递
Synergetic Effect of Yihuo Qingyi Decoction (益活凊胰汤) and Recombinant Staphylokinase in Treatment of Severe Acute Pancreatitis of Rats 被引量:3
12
作者 陈永峰 沙建平 吴仲敏 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2011年第2期103-106,共4页
Objective: To investigate the effect of recombinant staphylokinase (r-Sak) and the Chinese medicine Yihuo Qingyi Decoction (益活凊胰汤 Herbal decoction for severe acute pancreatitis) in the treatment of the severe acu... Objective: To investigate the effect of recombinant staphylokinase (r-Sak) and the Chinese medicine Yihuo Qingyi Decoction (益活凊胰汤 Herbal decoction for severe acute pancreatitis) in the treatment of the severe acute pancreatitis (SAP) in rats, and to observe the synergistic effect of the two. Methods: One hundred and sixty-two adult male SD rats with the body mass of 250–280 g were randomly divided into the following 5 groups: sham operation group (n=18), control group (n=36), Yihuo Qingyi Decoction treatment group (n=36), r-Sak treatment group (n=36), and Yihuo Qingyi Decoction plus r-Sak treatment group (n=36). The SAP ratmodel was prepared by retrograde injection of 5% sodium taurocholate into the cholangiopancreatic duct. Two days before modeling, Yihuo Qingyi Decoction was intragastrically administrated, and r-Sak was intraperitoneally injected. The survival rate within 18 h after modeling was determined. The pancreatic blood flow, the weight of ascites, and the serum amylase and lipase were investigated at 6 h, 12 h, and 18kh after modeling, and the pancreatic tissue was examined under light microscopy to see its pathological change. Results: The 18 h survival count of group A,B,C,D and E rats was 9,2,6,7 and 8 respectively. After r-Sak and Yihuo Qingyi Decoction intervention, the serum amylase and lipase and the weight of ascites were significantly decreased, especially in group E.18 h after modeling, the level of the serum amylase and lipase and the weight of ascites in group E was 1 100±118 U·L-1,1 000±150 U·L-1 and 13.40±1.80 g respectively, obviously lower than that of group B (P<0.05).After SAP was induced, the pancreatic blood flow showed a tendency to decrease, but the decrease extent in the treatment groups was smaller than that in the control group.18h after modeling, the pancreatic blood flow in group B and group E was 30.16±8.96 mL·100 g-1·min-1,and 129.10±42.58 mL·100 g-1·min-1 respectively, there was significant difference (P<0.05). The pathological change of the pancreatic tissue was alleviated in the treatment groups. Conclusion: Both r-Sak and Yihuo Qingyi Decoction play a beneficial role in the treatment of rat SAP and there is a synergistic effect between the two. 展开更多
关键词 Yihuo Qingyi Decoction (Herbal decoction for severe acute pancreatitis) Recombinant staphylokinase (r-Sak) Severe acute pancreatitis (SAP)
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部